Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Regulatory T-cell phenotypes in children with sickle cell disease

Abstract

Background

Regulatory T cells (Tregs) are linked to a reduction in alloreactive immune responses, but few studies have investigated the impact of hydroxyurea (HU) therapy on Tregs in sickle cell disease (SCD).

Methods

Our case-controlled study presented here included two groups, the first comprising 60 pediatric SCD patients, 30 of whom did not receive any treatment and 30 who received HU, and the second group consisting of 30 healthy controls. Flow cytometry was used to evaluate the percentage of CD4+CD25+highFoxp3+ Tregs present and their phenotypes.

Results

The percentage of CD4+CD25+high Tregs was significantly increased in untreated SCD patients in comparison to treated SCD patients and controls. Conversely, treated SCD children had a lower percentage of CD4+CD25+high Tregs than controls. In addition, a significant increase in the percentage of CD4+CD25+highFoxp3+ Tregs was found in untreated SCD patients, compared to in HU-treated patients and controls. The percentage of naive CD45RA+ Tregs was significantly decreased in untreated SCD patients when compared to other groups.

Conclusions

Among children with SCD, HU treatment exhibited significant qualitative and quantitative effects on Tregs by decreasing their frequency, and increasing the proportion of naive CD45RA+ Tregs and reducing levels of the most suppressive Tregs: HLA-DR+, CD39+, and CD69+.

Impact

  • Among children with, SCD, HU treatment exhibited significant qualitative and quantitative effects on Tregs.

  • HU treatment in SCD decreases the frequency of Tregs, as well as the levels of the most suppressive Tregs: HLA-DR+, CD39+, and CD69+. At the same time, HU increases the proportion of naive CD45RA+ Tregs.

  • Our study showed the impact of HU therapy on Tregs in children with SCD.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Flow cytometric detection of regulatory T cells phenotype.

References

  1. 1.

    Borhade, M. B., & Kondamudi, N. P. In StatPearls (StatPearls Publishing, 2020).

  2. 2.

    Emokpae, M. A. et al. Relationship between neutrophil-to-lymphocyte ratio and inflammatory markers in sickle cell anaemia patients with proteinuria. Med. Sci. 4, 11 (2016).

    Google Scholar 

  3. 3.

    Chou, S. T. et al. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 122, 1062–1071 (2013).

    CAS  Article  Google Scholar 

  4. 4.

    Zahran, A. M. et al. Circulating microparticles in children with sickle cell anemia in a tertiary center in upper Egypt. Clin. Appl Thromb. Hemost. 25, 1076029619828839 (2019).

    CAS  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Zahran, A. M. et al. Effect of hydroxyurea treatment on the inflammatory markers among children with sickle cell disease. Clin. Appl Thromb. Hemost. 26, 1076029619895111 (2020).

    CAS  Article  Google Scholar 

  6. 6.

    Yazdanbakhsh, K. Immunoregulatory networks in sickle cell alloimmunization. Hematol. Am. Soc. Hematol. Educ. Program 2016, 457–461 (2016).

    Article  Google Scholar 

  7. 7.

    Vignali, D. A. et al. How regulatory T cells work. Nat. Rev. Immunol. 8, 523 (2008).

    CAS  Article  Google Scholar 

  8. 8.

    Baecher-Allan, C. et al. MHC class II expression identifies functionally distinct human regulatory T cells. J. Immunol. 176, 4622–4631 (2006).

    CAS  Article  Google Scholar 

  9. 9.

    Vingert, B. et al. Partial dysfunction of Treg activation in sickle cell disease. Am. J. Hematol. 89, 261–266 (2014).

    CAS  Article  Google Scholar 

  10. 10.

    Youssry, I. et al. Enhancing effect of hydroxyurea on Hb F in sickle cell disease: ten-year egyptian experience. Hemoglobin 41, 267–273 (2017).

    CAS  Article  Google Scholar 

  11. 11.

    Charache, S. et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia. N. Engl. J. Med. 332, 1317–1322 (1995).

    CAS  Article  Google Scholar 

  12. 12.

    Rêgo, M. J. et al. Evaluation of CD4(+) CD25(+) FoxP3(+) T cell populations, IL-10 production, and their correlation with clinical and biochemical parameters in sickle cell anemia patients with leg ulcers. Cytokine 75, 310–315 (2015).

    Article  Google Scholar 

Download references

Acknowledgements

South Egypt Cancer Institute, Assiut, Egypt (No. 120-2017).

Author information

Affiliations

Authors

Contributions

A.M.Z., K.S., S.K., and A.E. designed the study, followed the patients, analyzed the data, and drafted the manuscript. A.Z. and H.F.H. performed all laboratory investigations in the study. K.I.E, K.S., and K.H.M. drafted the manuscript. All authors were involved in the critical analysis of the final version of the manuscript. All authors approved the manuscript as submitted and agree to be accountable for all aspects of the work.

Corresponding author

Correspondence to Khaled Saad.

Ethics declarations

Competing interests

The authors declare no competing interests.

Consent statement

All caregivers of all participants have given their informed written consent.

Ethical approval

All protocols and investigations of our study followed the regulations of the research ethics committee of Assiut University (No. 120-2017).

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zahran, A.M., Saad, K., Elsayh, K.I. et al. Regulatory T-cell phenotypes in children with sickle cell disease. Pediatr Res (2021). https://doi.org/10.1038/s41390-021-01627-y

Download citation

Search

Quick links